Escaping the hemoglobin A1C-Centric world in evaluating diabetes mellitus interventions

Journal of Diabetes Science and Technology

Volumn 9, Issue 5, 2015, Pages 1148-1151

  Vigersky, Robert A ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Diabetes mellitus; Glycemic control; Hemoglobin A1c; Hypoglycemia

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ANALYTICAL PARAMETERS; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); CONSENSUS DEVELOPMENT; DIABETES CONTROL; DIABETES MELLITUS; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; MEASUREMENT ACCURACY; NOCTURNAL HYPOGLYCEMIA; ORTHOPEDIC SOFTWARE; PATIENT EDUCATION; QUALITY OF LIFE; REVIEW; THRESHOLD LIMIT VALUE; WEIGHT GAIN; ANALYSIS; BLOOD; DIABETES MELLITUS, TYPE 2;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; QUALITY OF LIFE;

EID: 84969418852     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296815576363     Document Type: Review

References (17)

1. DCCT. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med. 1993; 329:977-986.
2. de Zoysa N, Rogers H, Stadler M, et al. A psychoeducational programme to restore hypoglycemia awareness, the DAFNE-HART pilot study. Diab Care. 2014; 37:863-866.
3. Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia. 2002; 45(7):937-948.
4. Rodbard D. A semilogarithmic scale for glucose provides a balanced view of hyperglycemia and hypoglycemia. J Diabetes Sci Tech. 2009; 3(6):1395-1401.
5. Bergenstal RM, Ahmann AJ, Bailey T, et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. J Diabetes Sci Technol. 2013; 7(2):562-578.
6. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: A patient-centered approach. Diab Care. 2012; 35:1364-1379.
7. Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a working group of the American Diabetes Association and the Endocrine Society. Diab Care. 2013; 36:1384-1395.
8. Handelsman Y, Mechanick JI, Blonde L, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011; 17(suppl 2):1-53.
9. Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporosis Int. 2001; 12:989-995
10. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care. 1987; 10:622-628.
11. Parkes JL, Slatin SL, Pardo S, Ginsberg BH. A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care. 2000; 23:1143-1148.
12. Passer ratings. Available at: http://en.wikipedia.org/wiki/Passer-rating. Accessed November 2014.
13. FDA Guidance for Industry. Diabetes mellitus: developing drugs and therapeutic biologics for treatment and prevention. December 2008. Available at: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm071627.pdf. Accessed January 2015.
14. Cefalu WT, Leiter LA, Yoon KH, et al. Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU: 52 week results from a randomised, double-blind, phase 3 non-inferiority trial. Lancet. 2013; 382:941-950.
15. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Eng J Med. 2008; 359:1464-1476.
16. Bergenstal RM, Klonoff DC, Garg SK, et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Eng J Med. 2013; 369:224-232.
17. American Diabetes Association Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care. 2005; 28:1245-1249.